The Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...

The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

More than one million people in the United States live with Multiple Sclerosis (MS), a chronic neurological disease that ...

With the right strategies, you can ‘treat the treatment’ and use your MS medications reliably and successfully.

Selma Blair has revealed she's been "feeling great for about a year" after being diagnosed with multiple sclerosis in 2018.

The Patient-Centered Outcomes Research Institute (PCORI) gave the Cleveland Clinic $6.7 million to identify optimal RRMS ...

Researchers have identified a new biomarker in multiple sclerosis (MS): the thickness of the inflammatory rim surrounding ...

A novel AI tool called MindGlide extracts key biomarkers from MRI scans to help interpret and assess treatment efficacy in ...

Assessing multiple sclerosis disease activity using the MSDA blood biomarker test can help guide decisions about care, per a ...

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple ...